Close Menu

This article has been updated with additional information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported flat sales for its diagnostics division in the first quarter of 2019, driven by decreased sales in the centralized and point-of-care business and diabetes care business that were partially offset by strong growth in its molecular diagnostics business.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.